CG Oncology Inc. Common s...
(CGON)
undefined
undefined%
At close: undefined
30.80
3.60%
Pre-market Jan 07, 2025, 04:45 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 |
| Net Income | -48.61M | -35.44M | -12.84M |
| Depreciation & Amortization | 17.00K | 15.00K | 10.00K |
| Stock-Based Compensation | 1.53M | 676.00K | 1.11M |
| Other Working Capital | 1.43M | 4.46M | -2.54M |
| Other Non-Cash Items | -2.06M | 1.23M | 584.00K |
| Deferred Income Tax | n/a | n/a | n/a |
| Change in Working Capital | 3.44M | 4.44M | -1.97M |
| Operating Cash Flow | -45.68M | -29.80M | -13.65M |
| Capital Expenditures | n/a | -14.00K | -97.00K |
| Acquisitions | n/a | n/a | n/a |
| Purchase of Investments | -517.61M | -55.34M | n/a |
| Sales Maturities Of Investments | 396.42M | n/a | n/a |
| Other Investing Acitivies | n/a | -55.34M | n/a |
| Investing Cash Flow | -121.19M | -55.35M | -97.00K |
| Debt Repayment | -16.29M | n/a | 15.20M |
| Common Stock Repurchased | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a |
| Other Financial Acitivies | 104.63M | 119.53M | n/a |
| Financial Cash Flow | 87.00M | 119.69M | 15.45M |
| Net Cash Flow | -79.88M | 34.54M | 1.70M |
| Free Cash Flow | -45.68M | -29.82M | -13.75M |